145 related articles for article (PubMed ID: 1968251)
1. Amperozide and conditioned behaviour in rats: potentiation by classical neuroleptics and alpha-methylparatyrosine.
Egbe P; Engel J; Gustafsson B; Christensson E
Pharmacol Toxicol; 1990; 66 Suppl 1():18-21. PubMed ID: 1968251
[TBL] [Abstract][Full Text] [Related]
2. Potentiation by alpha-methyltyrosine of the suppression of food-reinforced lever-pressing behaviour induced by antipsychotic drugs.
Ahlenius S; Engel J
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):115-25. PubMed ID: 13605
[TBL] [Abstract][Full Text] [Related]
3. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
Gustafsson B; Christensson E
Pharmacol Toxicol; 1990; 66 Suppl 1():12-7. PubMed ID: 1968250
[TBL] [Abstract][Full Text] [Related]
4. Effects of amperozide on induced turning behaviour in 6-OHDA lesioned rats.
Christensson EG
Pharmacol Toxicol; 1990; 66 Suppl 1():22-8. PubMed ID: 2106130
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat.
Mobini S; Chiang TJ; Ho MY; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2000 Sep; 152(1):47-54. PubMed ID: 11041315
[TBL] [Abstract][Full Text] [Related]
6. The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization.
Waters N; Pettersson G; Carlsson A; Svensson K
Naunyn Schmiedebergs Arch Pharmacol; 1989 Aug; 340(2):161-9. PubMed ID: 2572972
[TBL] [Abstract][Full Text] [Related]
7. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
Barghon R; Protais P; Colboc O; Costentin J
Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of conditioned avoidance response by a new neuroleptic (LR 511). Interference with drugs endowed with different CNS activity.
Chieli T; Fregnan GB
Pharmacol Res Commun; 1979 Jul; 11(7):617-22. PubMed ID: 41268
[No Abstract] [Full Text] [Related]
9. Potentiation of the haloperidol-induced blockade of a conditioned avoidance response by alpha-methyltyrosine.
Monti JM; Ruiz M
Eur J Pharmacol; 1973 Oct; 24(1):25-8. PubMed ID: 4756166
[No Abstract] [Full Text] [Related]
10. Effect of amperozide on the synthesis and turnover of monoamines in rat brain.
Pettersson G; Johannessen K; Hulthe P; Engel JA
Pharmacol Toxicol; 1990; 66 Suppl 1():40-4. PubMed ID: 2106131
[TBL] [Abstract][Full Text] [Related]
11. Amperozide and emotional behaviour.
Gustafsson B; Christensson E
Pharmacol Toxicol; 1990; 66 Suppl 1():34-9. PubMed ID: 2304894
[TBL] [Abstract][Full Text] [Related]
12. The acute effect of timiperone on the alpha-MT-induced dopamine fluorescence in rat brain.
Kojima H; Suetake K; Tsutsumi T; Anraku S; Inanaga K
Kurume Med J; 1982; 29(2):93-5. PubMed ID: 6132022
[No Abstract] [Full Text] [Related]
13. Differential effects of clozapine, metoclopramide, haloperidol and risperidone on acquisition and performance of operant responding in rats.
Baker TW; Florczynski MM; Beninger RJ
Psychopharmacology (Berl); 2015 May; 232(9):1535-43. PubMed ID: 25381749
[TBL] [Abstract][Full Text] [Related]
14. Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
den Boon FS; Body S; Hampson CL; Bradshaw CM; Szabadi E; de Bruin N
J Psychopharmacol; 2012 Sep; 26(9):1231-43. PubMed ID: 21969105
[TBL] [Abstract][Full Text] [Related]
15. Amperozide--effect on prolactin release in the rat.
Albinsson A; Eriksson E; Andersson G
Pharmacol Toxicol; 1990; 66 Suppl 1():49-51. PubMed ID: 2304896
[TBL] [Abstract][Full Text] [Related]
16. Effect of amperozide on the dopamine synthesis activity in the tuberoinfundibular neurons.
Andersson G; Albinsson A; Pettersson G
Arzneimittelforschung; 1990 Mar; 40(3):237-9. PubMed ID: 2111999
[TBL] [Abstract][Full Text] [Related]
17. A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802.
White IM; Ciancone MT; Haracz JL; Rebec GV
Pharmacol Biochem Behav; 1992 Jan; 41(1):29-35. PubMed ID: 1347175
[TBL] [Abstract][Full Text] [Related]
18. Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats.
Uvnäs-Moberg K; Alster P; Svensson TH
Psychopharmacology (Berl); 1992; 109(4):473-6. PubMed ID: 1365865
[TBL] [Abstract][Full Text] [Related]
19. Use of DRL in differentiating anxiolytic and neuroleptic properties of CNS drugs.
Canon JG; Lippa AS
Pharmacol Biochem Behav; 1977 May; 6(5):591-3. PubMed ID: 19772
[TBL] [Abstract][Full Text] [Related]
20. Effects of neuroleptics on rate and duration of operant versus reflexive licking in rats.
Gramling SE; Fowler SC
Pharmacol Biochem Behav; 1985 Apr; 22(4):541-5. PubMed ID: 2859612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
